AI-Driven Pathology and Blood-Based Biomarkers: A Golden Opportunity to Democratize Precision Oncology

Post time 7 day(s) ago

journal：Cancer Discovery

Authors：Danh-Tai Hoang; Tian-Gen Chang; Cristina R. Ferrone; Ze’ev A. Ronai; Eytan Ruppin

Published date：2026-5-1

DOI：10.1158/2159-8290.cd-25-2065

PDF link：https://aacrjournals.org/cancerd ... 5787/cd-25-2065.pdf

Article link：https://doi.org/10.1158/2159-8290.cd-25-2065

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 7 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] AI-Driven Pathology and Blood-Based Biomarkers: A Golden Opportunity to Democratize Precision Oncology

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] AI-Driven Pathology and Blood-Based Biomarkers: A Golden Opportunity to Democratize Precision Oncology Copy